Clinical trials
Phase 2 Sarcoma, Ewing trials in France
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
7 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 1 |
| 2008 | 1 |
| 2010 | 1 |
| 2014 | 2 |
| 2022 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 3 |
| Active, not recruiting | 2 |
| Recruiting | 1 |
| Unknown status | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Eli Lilly and Company | 2 |
| Gustave Roussy, Cancer Campus, Grand Paris | 1 |
| Institut Bergonié | 1 |
| National Cancer Institute (NCI) | 1 |
| PharmaMar | 1 |
| University of Oxford | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Sarcoma, Ewing | 7 |
| Osteosarcoma | 3 |
| Neuroectodermal Tumors, Primitive | 2 |
| Rhabdomyosarcoma | 2 |
| Sarcoma | 2 |
| Histiocytoma, Malignant Fibrous | 1 |
| Leiomyosarcoma | 1 |
| Medulloblastoma | 1 |
| Neoplasm Metastasis | 1 |
| Neoplasms, Connective and Soft Tissue | 1 |
Trials
Showing 1 to 7 of 7. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.